Cancer Immunology A Translational Medicine Context /
Cancer Immunology is intended as an up-to-date, clinically relevant review of cancer immunology and immunotherapy. The rapid flow of studies in the field of cancer immunology during the last decade has increased our understanding of the interactions between the immune system and cancerous cells. In...
| Συγγραφή απο Οργανισμό/Αρχή: | |
|---|---|
| Άλλοι συγγραφείς: | |
| Μορφή: | Ηλεκτρονική πηγή Ηλ. βιβλίο |
| Γλώσσα: | English |
| Έκδοση: |
Berlin, Heidelberg :
Springer Berlin Heidelberg : Imprint: Springer,
2015.
|
| Θέματα: | |
| Διαθέσιμο Online: | Full Text via HEAL-Link |
Πίνακας περιεχομένων:
- Introduction on cancer immunology and immunotherapy
- Inflammatory and innate immune cells in cancer microenvironment and progression
- Role of innate immunity in cancers and antitumor response
- Role of B cells in anti tumor response
- The role of exhaustion in tumor-induced T cell dysfunction in patients with cancer
- Regulatory T cells and Th17 cells in the immunosuppressive tumor network
- Role of cytokines in tumor immunity and immune tolerance to cancers
- Role of chemokines and chemokine receptors in cancers
- The role of Fas and Fas-ligand in cancers
- MHC class I molecules and cancer progression: Lessons learned from preclinical tumor models
- Role of plasmacytoid dendritic cells in cancer
- Cancer immunoediting: immunosurveillance, immuneequilibrium, and immune escape
- Apoptosis, autophagy and necroptosis in Cancer
- Prognostic value of innate and adaptive immunity in cancers
- Epigenetics and Micro RNAs in cancers
- Immunogenetics of cancers
- Immunodeficiencies and cancers
- Immunosenescence and cancers
- Nutrition, immunity and cancers
- Allergies and cancers
- Cancer immunology of transmissible cancers
- Systems biology and systems immunology of cancer
- Principles of immunological diagnostic tests for cancers
- Flow cytometry in cancer immunotherapy: applications, analysis, quality control and future
- Immunohistochemistry of cancers
- Immunology and immunotherapy of graft versus host disease. .
